Citation Impact
Citing Papers
Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2014
Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
2008
First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
2014
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
2018
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
2014
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
2011
Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients
2010
Head and neck squamous cell carcinoma
2020 Standout
Clinical update on head and neck cancer: molecular biology and ongoing challenges
2019
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
The Surgical Palliation of Advanced Head and Neck Cancer using Photodynamic Therapy
2010
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Radiation-induced lung injury
2003
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer
2004
Nasopharyngeal carcinoma
2019 Standout
Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma
2011
Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer
2015
Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study
2015
An overview of application of silver nanoparticles for biomaterials in dentistry
2018 Standout
T cell pathology in skin inflammation
2019
Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacy
1989
Nasopharyngeal carcinoma
2015 Standout
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Next generation of immune checkpoint therapy in cancer: new developments and challenges
2018
Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions
2016
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
2019
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Photodynamic therapy of cancer: An update
2011 Standout
Hidradenitis suppurativa
2020 Standout
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
2020
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling
2018
Targeting TGF-β Signaling in Cancer
2017
Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models
2017
Doxorubicin-Induced Cardiomyopathy
1998 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Integrin αβ1, αvβ, α6β effectors p130Cas, Src and talin regulate carcinoma invasion and chemoresistance
2011
The Chemistry of Curcumin: From Extraction to Therapeutic Agent
2014 Standout
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
2013
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination
2015
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN
2016
Facile bio-synthesis of gold nanoparticles by using extract of Hibiscus sabdariffa and evaluation of its cytotoxicity against U87 glioblastoma cells under hyperglycemic condition
2015 Standout
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Flavonoids in Cancer and Apoptosis
2018 Standout
Synthesis of methotrexate-conjugated gold nanoparticles with enhanced cancer therapeutic effect
2013
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Pol Specenier being referenced
Pembrolizumab use for the treatment of advanced melanoma
2017
Optimal treatment for recurrent/metastatic head and neck cancer
2010
Cetuximab: its unique place in head and neck cancer treatment
2013
Afatinib in squamous cell carcinoma of the head and neck
2016
Sequential treatment with vindesine–ifosfamide–platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A phase II trial1Data presented in part at the 61st Annual International Scientific Assembly of the American College of Chest Physicians, New York, NY, USA, 31 October 1995.1
1998
Incorporating Anti-VEGF Pathway Therapy as a Continuum of Care in Metastatic Colorectal Cancer
2015
Neoadjuvant chemotherapy in head and neck cancer: Should it be revisited?
2007
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
2016
Current concepts for the management of head and neck cancer: Chemotherapy
2008
Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients
2008
Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins
2014
Recurrent head and neck cancer: current treatment and future prospects
2008
Nivolumab in squamous cell carcinoma of the head and neck
2018
Weekly low-dose doxorubicin in advanced breast cancer.
1986
Nivolumab in melanoma
2016
A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy
2010
Safety interim data from a three-arm phase II study evaluating safety and pharmacokinetics of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 monohydrate in patients with glioblastoma at first progression.
2013